期刊文献+

氧化低密度脂蛋白和C反应蛋白与冠状动脉支架置入术后再狭窄的关系研究 被引量:6

Relationships of oxidized low-density lipoproteins and C reactive protein with in-stent restenosis after PCI
在线阅读 下载PDF
导出
摘要 目的:探讨氧化低密度脂蛋白(ox-LDL)、C 反应蛋白(CRP)对经皮冠状动脉介入治疗(PCI)术后支架内再狭窄(ISR)的预测价值。方法选择行 PCI 术并于术后6个月内接受冠状动脉造影复查的患者186例,其中术后发生 ISR (ISR 组)22例,无 ISR 发生(非 ISR 组)164例。检测两组 PCI 术前和术后血清 ox-LDL、CRP水平。结果 ISR 组和非 ISR 组年龄、性别构成、合并症、血脂水平、血管病变情况等一般资料差异均无统计学意义(P >0.05)。 ISR 组 PCI 术后 ox-LDL、CRP 水平明显高于术前(P <0.05),而非 ISR 组 PCI 术前和术后ox-LDL、CRP 水平无明显改变(P >0.05)。 ISR 组术前、术后 ox-LDL 水平均高于非 ISR 组(P <0.05);术前2组CRP 水平差异无统计学意义(P >0.05),术后 ISR 组明显高于非 ISR 组(P <0.05)。相关分析显示 ISR 组、非ISR 组无论是 PCI 术前还是 PCI 术后,ox-LDL 与 CRP 均呈正相关[ISR 组:术前、术后 r 值(P 值)分别为0.392(0.020)、0.431(0.010);非 ISR 组:术前、术后 r 值(P 值)分别为0.382(0.024)、0.526(0.001)];Logistic回归分析显示术后 ox-LDL[优势比(OR)=1.27,95%可信区间(CI):1.05~1.79]和术前 CRP 水平(OR =1.82,95%CI:1.68~2.30)是 ISR 的独立危险因子。结论 PCI 术后 ox-LDL 和术前 CRP 水平升高对预测 ISR 发生有一定的临床价值。 Objective To investigate the predictive significance of oxidized low-density lipoproteins (ox-LDL) and C reactive protein (CRP) for in-stent restenosis (ISR) after percutaneous coronary intervention (PCI). Methods A total of 186 patients who were given PCI and followed up for 6 months were enrolled.Of them, 22 patients had ISR(ISR group), while the other 164 patients had not ISR(no-ISR group).The pre-and post-PCI serum ox-LDL and CRP were detected.Results There was no statistical significance between the 2 groups in terms of age, sex, morbidity, serum lipid and vessel lesion(P 〉0.05).Serum ox-LDL and CRP increased significantly in ISR group at post-PCI compared with pre-PCI (P 〈0.05), while there was no significant change in no-ISR group (P〉0.05).Serum ox-LDL were also higher in ISR group compared with no-ISR group at pre-and post-PCI (P 〈0.05).There was no statistical significance for CRP level between the 2 groups at pre-PCI (P >0.05).However, the significant increase of CRP level in ISR group compared with no-ISR group was present at post-PCI (P 〈0.05).Correlation analysis revealed that there was positive correlation between pre-and post-PCI for serum ox-LDL and CRP in both ISR and no-ISR groups [ISR group: r(P) values of pre-and post-PCI were 0.392 (0.020) and 0.431 (0.010); no-ISR group: r(P) values of pre-and post-PCI were 0.382 (0.024) and 0.526 (0.001)].The Logistic regression analysis showed that post-PCI ox-LDL [odds ratio (OR) =1.27, 95% confidence interval (CI): 1.05-1.79] and pre-PCI CRP (OR =1.82,95%CI:1.68-2.30) were independent risk factors of ISR.Conclusions Post-PCI ox-LDL and pre-PCI CRP have certain significance in the prediction of ISR.
出处 《检验医学》 CAS 2015年第5期484-488,共5页 Laboratory Medicine
基金 广西医药卫生科学研究基金资助项目(Z2012636)
关键词 氧化低密度脂蛋白 C 反应蛋白 经皮冠状动脉介入 再狭窄 Oxidized low-density lipoprotein C reactive protein Percutaneous coronary intervention In-stent restenosis
作者简介 作者简介:何文军,男,1972年生,学士,主任技师,主要从事临床免疫学检验工作。
  • 相关文献

参考文献16

  • 1SIMON DI. Inflammation and vascular injury: basic discovery to drug development[ J]. Circ J, 2012, 76 (8) :1811-1818.
  • 2NARUKO T, UEDA M, EHARA S,et al. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis [ J ]. Arterioscler Thromb Vasc Biol,2006, 26 (4) : 877-883.
  • 3LAN Z, LYU Y, XIAO J, et al. Novel biodegradable drug-eluting stent composed of poly-L-lactic acid and amorphous calcium phosphate nanopartieles demonstrates improved structural and functional performance for coronary artery disease[ J]. J BiomedNanotechnol, 2014, 10 (7) : 1194-1204.
  • 4KASTRATI A, MEHILLI J, VON BECKERATH N, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis : a randomized controlled trial [ J 1- JAMA, 2005,293 (2) :165-171.
  • 5CT N,PIBAROT P,PI~PIN A,et al. Oxidized low- density lipoprotein, angiotensin 1] and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis [ J ]. Int J Cardiol,2010,145 (3) :444-449.
  • 6陈帅,贺能树.血管支架内再狭窄的研究进展[J].国际医学放射学杂志,2011,34(4):349-352. 被引量:6
  • 7MULLER O, NTALIANIS A, WIJNS W, et al. Association of biomarkers of lipid modification with functional and morphological indices of coronary stenosis severity in stable coronary artery disease [ J 1. J Cardiovasc Transl Res ,2013,6 (4) :536-544.
  • 8葛庆峰,闫杰,白华.血清氧化型低密度脂蛋白自身抗体水平与冠状动脉病变程度的关系[J].陕西医学杂志,2005,34(8):944-946. 被引量:2
  • 9KARACA I, AYDIN K, YAVUZKIR M, et al. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation[ J]. J Int Med Res,2005,33 (4) : 389-396.
  • 10马燚,闫华,姜玉凤.C-反应蛋白与冠状动脉支架置入术后再狭窄的关系[J].中国煤炭工业医学杂志,2005,8(8):868-869. 被引量:3

二级参考文献51

  • 1武晓静,黄岚,晋军,宋明宝,于世勇.紫杉醇对培养的兔血管平滑肌细胞和内皮细胞增生与迁移的影响及其相互关系[J].中华心血管病杂志,2004,32(7):626-630. 被引量:11
  • 2Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease [ J ]. N Engl J Med, 1994,331: 496-501.
  • 3Levine GN, Kern MJ, Berger PB, et al. Management of patients undergoing percutaneous coronary revaseularization [J 3. Ann Intern Med, 2003,139:123-136.
  • 4Carter A J, Laird JR, Farb A, et al. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model [J ]. J Am Coll Cardiol, 1994,24:1398 - 1405.
  • 5Mitra AK, Agrawal DK. In stent restenosis: bane of the stent era[J].J Clin Patho1,2006,59:232-239.
  • 6Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity [ J ]. Cell, 1990,61:203 - 212.
  • 7Davis RJ. MAPKs: new JNK expands the group [J]. Trends Biochem Sci,1994, 19: 470-473.
  • 8Matte BM, Downward J. PKB/Akt: connecting phosphoinositide 3- kinase to cell survival and beyond[J]. Trends Biochem Sci,1997,22: 355-358.
  • 9Coffer PJ, Jin J, Woodgett JR. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation [J ]. Biochem J,1998,335:1-13.
  • 10Newby AC, Lim K, Evans MA, et al. Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C [J ]. Br J Pharmacol,1995,114:1652-1656.

共引文献8

同被引文献38

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部